China Cord Blood (CO) Tops Q3 EPS by 5c

China Cord Blood (NYSE: CO) reported Q3 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $27 million.

New subscribers and accumulated subscriber base were 15,603 and 489,796, respectively. The new subscriber number decreased by 11.5% year-over-year.

For earnings history and earnings-related data on China Cord Blood (CO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• L3Harris CEO steps down amid conduct review, shares drop